Therapeutic area intelligence for Male Infertility with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 2

Companies

biotech companies in reproductive health →

L-Carnitine →

Assets

Letrozole →

Recent signals(2)

ClinicalJuly 10, 2026

MT-ND1 Mutation Linked to Male Infertility in Chinese Population

The study identifies a significant association between the MT-ND1 m.3700G>A mutation and impaired sperm production in men with idiopathic non-obstructive azoospermia.

ClinicalJune 29, 2026

Trial Evaluates Letrozole and L-Carnitine for Sperm Quality in Oligoasthenoteratozoospermia

A randomized trial is assessing the effects of Letrozole and L-Carnitine on sperm quality and ART outcomes in men with idiopathic oligoasthenoteratozoospermia.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.